COMPANY NEWS

3D SIGNATURES’ TELOVIEW™ SOFTWARE IDENTIFIES AND STAGES PATIENTS WITH ALZHEIMER’S DISEASE FROM A CHEEK SWAB

March 21, 2017
WINNIPEG, MB (March 21, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), is pleased to announce...
Read More

3D SIGNATURES MAKES FINAL PATENT PAYMENT

March 14, 2017
WINNIPEG, MB (March 14, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), is pleased to announce...
Read More

3D SIGNATURES INC. REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS

March 2, 2017
WINNIPEG, MB (March 2, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), today reported operational and...
Read More

3D SIGNATURES INC. INITIATES HODGKIN’S LYMPHOMA VALIDATION PROGRAM

February 23, 2017
WINNIPEG, MB (February 23, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), is pleased to announce...
Read More

3D SIGNATURES TO PRESENT POSITIVE RESULTS FOR PROSTATE CANCER LIQUID BIOPSY

February 21, 2017
WINNIPEG, MB (February 21, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS") is pleased to announce...
Read More

3D SIGNATURES INC. ADDS MEDICAL DIAGNOSTIC EXPERT TO BUSINESS ADVISORY BOARD

February 15, 2017
WINNIPEG, MB (February 15, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), is pleased to announce...
Read More

3D SIGNATURES INC. TO PRESENT AT THE NOBLE FINANCIAL CAPITAL MARKETS’ 13TH ANNUAL INVESTOR CONFERENCE

January 25, 2017
WINNIPEG, MB (January 25, 2017) − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), today announced that its...
Read More

3D SIGNATURES INC. ANNOUNCES GRANT OF STOCK OPTIONS

January 18, 2017
WINNIPEG, Manitoba, Jan. 18, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), announces that...
Read More

3D SIGNATURES INC. PROVIDES FURTHER DETAIL ON KILMER LUCAS ENGAGEMENT

January 16, 2017
WINNIPEG, Manitoba, Jan. 16, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased...
Read More

NEW STUDY SHOWS 3D SIGNATURES’ TELOMERE ANALYSIS MAY BE AN EFFECTIVE BIOMARKER FOR MONITORING HIGH RISK PROSTATE CANCER PATIENTS

January 9, 2017
Ability of 3DS' TeloView™ to Measure Genomic Instability Could Improve Patient Monitoring and Management   WINNIPEG, MB--(Marketwired - January 09,...
Read More
1 2 3 6